Latest articles and price-sensitive announcements with AI sentiment classification.
Amid stubbornly high syphilis rates, pandemic-era Atomo is developing a point-of-care assay to detect active cases of the venereal disease. ... Read More The post Biocurious: Atomo is girding for the STD ‘comeback tour’ no-one wants to see appeared first on Stockhead.
other announcement
other announcement
other announcement
Atomo Diagnostics (ASX:AT1) Shares Gain 5.56% as Rapid-Test Platform Remains in Focus Kalkine
other announcement
Atomo Diagnostics Limited (ASX:AT1) Share Price Remains Unchanged as Stock Trades Within Daily Range Kalkine
other announcement
Atomo Diagnostics (ASX:AT1) Edges Up 6.25% as Point-of-Care Testing Strategy Progresses Kalkine
Insider Buyers Lose AU$30k As Atomo Diagnostics Sheds AU$1.8m simplywall.st
The placement is priced at a discount of about 10% to the 15-day volume weighted average price.x ... Read More The post Atomo Diagnostics raising $4m to scale-up Pascal cassette supply amidst expected demand growth appeared first on Stockhead.
Atomo Diagnostics (ASX:AT1) Raises A$4m as FebriDx CLIA Waiver Unlocks Pascal Volume Upside Stocks Down Under
other announcement
other announcement
other announcement
other announcement
other announcement
other announcement
director_dealing announcement
Stockhead
ASX
Google News